Renal cell carcinoma presenting as exfoliative dermatitis (erythroderma) -- a case report.
- Published in:
- Clinical Nephrology, 2013, v. 80, n. 1, p. 63, doi. 10.5414/CN107319
- By:
- Publication type:
- Article
Works matching AU Fan, Yidong
Results: 39
1
2
Genomic, epigenomic, and transcriptomic signatures for telomerase complex components: a pan‐cancer analysis.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 1, p. 150, doi. 10.1002/1878-0261.13324
- By:
- Publication type:
- Article
3
Negative association between 15 obesity- and lipid-related indices and testosterone in adult males: a population based cross-sectional study.
- Published in:
- Lipids in Health & Disease, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12944-025-02436-6
- By:
- Publication type:
- Article
4
Prognostic Significance of Cyclin D1 Expression in Renal Cell Carcinoma: a Systematic Review and Meta-analysis.
- Published in:
- Pathology & Oncology Research, 2020, v. 26, n. 3, p. 1401, doi. 10.1007/s12253-019-00776-0
- By:
- Publication type:
- Article
5
Clinical, Pathological, and Prognostic Analysis of Urachal Carcinoma.
- Published in:
- Urologia Internationalis, 2022, v. 106, n. 2, p. 199, doi. 10.1159/000518028
- By:
- Publication type:
- Article
6
The chromosomal instability 25 gene signature is identified in clear cell renal cell carcinoma and serves as a predictor for survival and Sunitinib response.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1133902
- By:
- Publication type:
- Article
7
The cuproptosis-associated 11 gene signature as a predictor for outcomes and response to Bacillus Calmette-Guerin and immune checkpoint inhibitor therapies in bladder carcinoma .
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1126247
- By:
- Publication type:
- Article
8
The cuproptosis-associated 13 gene signature as a robust predictor for outcome and response to immune- and targeted-therapies in clear cell renal cell carcinoma.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.971142
- By:
- Publication type:
- Article
9
MicroRNA-153-5p promotes the proliferation and metastasis of renal cell carcinoma via direct targeting of AGO1.
- Published in:
- Cell Death & Disease, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41419-020-03306-y
- By:
- Publication type:
- Article
10
Berberine enhances gemcitabine-induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway.
- Published in:
- Oncology Reports, 2022, v. 47, n. 2, p. N.PAG
- By:
- Publication type:
- Article
11
Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells.
- Published in:
- Journal of Pathology, 2011, v. 225, n. 2, p. 203, doi. 10.1002/path.2914
- By:
- Publication type:
- Article
12
Switch to full-length of XAF1 mRNA expression in prostate cancer cells by the DNA methylation inhibitor.
- Published in:
- International Journal of Cancer, 2006, v. 118, n. 10, p. 2485, doi. 10.1002/ijc.21636
- By:
- Publication type:
- Article
13
GABPA-activated TGFBR2 transcription inhibits aggressiveness but is epigenetically erased by oncometabolites in renal cell carcinoma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02382-6
- By:
- Publication type:
- Article
14
Unenhanced low-dose versus standard-dose CT localizationin patients with upper urinary calculi for minimally invasive percutaneous nephrolithotomy (MPCNL).
- Published in:
- Indian Journal of Medical Research, 2014, v. 139, n. 3, p. 386
- By:
- Publication type:
- Article
15
Identification and validation of m6A‐associated ferroptosis genes in renal clear cell carcinoma.
- Published in:
- Cell Biology International, 2024, v. 48, n. 6, p. 777, doi. 10.1002/cbin.12146
- By:
- Publication type:
- Article
16
SMYD3 as an Oncogenic Driver in Prostate Cancer by Stimulation of Androgen ReceptorTranscription.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 22, p. 1719, doi. 10.1093/jnci/djt304
- By:
- Publication type:
- Article
17
A five-gene signature predicts overall survival of patients with papillary renal cell carcinoma.
- Published in:
- PLoS ONE, 2019, v. 14, n. 3, p. 1, doi. 10.1371/journal.pone.0211491
- By:
- Publication type:
- Article
18
FTO promotes tumour proliferation in bladder cancer via the FTO/miR-576/CDK6 axis in an m6A-dependent manner.
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00724-5
- By:
- Publication type:
- Article
19
Correction: FTO promotes tumour proliferation in bladder cancer via the FTO/miR-576/CDK6 axis in an m6A-dependent manner.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
20
FTO promotes tumour proliferation in bladder cancer via the FTO/miR-576/CDK6 axis in an m6A-dependent manner.
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00724-5
- By:
- Publication type:
- Article
21
FTO promotes tumour proliferation in bladder cancer via the FTO/miR-576/CDK6 axis in an m6A-dependent manner.
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00724-5
- By:
- Publication type:
- Article
22
Laparoscopic pyelotomy combined with ultrasonic lithotripsy via a nephroscope for the treatment of complex renal stones.
- Published in:
- Urolithiasis, 2024, v. 52, n. 1, p. 1, doi. 10.1007/s00240-023-01522-7
- By:
- Publication type:
- Article
23
Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma.
- Published in:
- Biology of Sex Differences, 2023, v. 14, n. 1, p. 1, doi. 10.1186/s13293-023-00526-7
- By:
- Publication type:
- Article
24
CTCF-activated FUCA1 functions as a tumor suppressor by promoting autophagy flux and serum α-L-fucosidase serves as a potential biomarker for prognosis in ccRCC.
- Published in:
- Cancer Cell International, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12935-024-03502-2
- By:
- Publication type:
- Article
25
The Anticancer Effect of Huaier Extract in Renal Cancer 786-O Cells.
- Published in:
- Pharmacology, 2018, v. 102, n. 5/6, p. 316, doi. 10.1159/000492935
- By:
- Publication type:
- Article
26
Identification of a novel prognostic and therapeutic prediction model in clear cell renal carcinoma based on Renin-angiotensin system related genes.
- Published in:
- Frontiers in Endocrinology, 2025, p. 1, doi. 10.3389/fendo.2025.1521940
- By:
- Publication type:
- Article
27
Laparoscopic pyelotomy combined with ultrasonic lithotripsy via a nephroscope for the treatment of complex renal stones.
- Published in:
- Urolithiasis, 2024, v. 52, n. 1, p. 1, doi. 10.1007/s00240-023-01522-7
- By:
- Publication type:
- Article
28
Huaier Extract Inhibits Prostate Cancer Growth via Targeting AR/AR-V7 Pathway.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.615568
- By:
- Publication type:
- Article
29
Nomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma.
- Published in:
- OncoTargets & Therapy, 2018, v. 11, p. 5535, doi. 10.2147/OTT.S171881
- By:
- Publication type:
- Article
30
Transcriptional Regulation of 15-Lipoxygenase Expression by Histone H3 Lysine 4 Methylation/ Demethylation.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0052703
- By:
- Publication type:
- Article
31
Analysis of key genes in osteosarcoma based on bioinformatics and qRT-PCR experimental verifi cation.
- Published in:
- Journal of Practical Oncology, 2024, v. 39, n. 4, p. 344, doi. 10.13267/j.cnki.syzlzz.2024.051
- By:
- Publication type:
- Article
32
TERT Promoter Hypermethylation in Gastrointestinal Cancer: A Potential Stool Biomarker.
- Published in:
- Oncologist, 2017, v. 22, n. 10, p. 1178, doi. 10.1634/theoncologist.2017-0064
- By:
- Publication type:
- Article
33
TERT Promoter Mutations and TERT mRNA but Not FGFR3 Mutations Are Urinary Biomarkers in Han Chinese Patients With Urothelial Bladder Cancer.
- Published in:
- Oncologist, 2015, v. 20, n. 3, p. 263, doi. 10.1634/theoncologist.2014-0391
- By:
- Publication type:
- Article
34
Multi-Omics Analysis of the Expression and Prognosis for FKBP Gene Family in Renal Cancer.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.697534
- By:
- Publication type:
- Article
35
Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson's Disease.
- Published in:
- Parkinson's Disease (20420080), 2020, p. 1, doi. 10.1155/2020/4981647
- By:
- Publication type:
- Article
36
Urinary Dysfunction Is Associated with Nigrostriatal Dopaminergic Degeneration in Early and Untreated Patients with Parkinson's Disease.
- Published in:
- Parkinson's Disease (20420080), 2020, p. 1, doi. 10.1155/2020/4981647
- By:
- Publication type:
- Article
37
Integral Analysis of the RNA Binding Protein-associated Prognostic Model for Renal Cell Carcinoma.
- Published in:
- International Journal of Medical Sciences, 2021, v. 18, n. 4, p. 953, doi. 10.7150/ijms.50704
- By:
- Publication type:
- Article
38
Eukaryotic translation initiation factor 3 subunit b is a novel oncogenic factor in prostate cancer.
- Published in:
- Mammalian Genome, 2020, v. 31, n. 7/8, p. 197, doi. 10.1007/s00335-020-09842-4
- By:
- Publication type:
- Article
39
Giant Paraganglioma Complicated With Catecholamine Crisis and Catecholamine Cardiomyopathy: A Case Report and Review of the Literature.
- Published in:
- 2022
- By:
- Publication type:
- Case Study